HTG Molecular Diagnostics (STU:65H) Asset Impairment Charge : €0.00 Mil (TTM As of Mar. 2023)

View and export this data going back to 2017. Start your Free Trial

What is HTG Molecular Diagnostics Asset Impairment Charge?

HTG Molecular Diagnostics's Asset Impairment Charge for the three months ended in Mar. 2023 was €0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2023 was €0.00 Mil.

HTG Molecular Diagnostics Asset Impairment Charge Historical Data

The historical data trend for HTG Molecular Diagnostics's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HTG Molecular Diagnostics Asset Impairment Charge Chart

HTG Molecular Diagnostics Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Asset Impairment Charge

Get a 7-Day Free Trial

0.10

0.02

HTG Molecular Diagnostics Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Asset Impairment Charge	Get a 7-Day Free Trial															-	-	-	-	-

HTG Molecular Diagnostics Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

HTG Molecular Diagnostics Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of HTG Molecular Diagnostics's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

HTG Molecular Diagnostics (STU:65H) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » HTG Molecular Diagnostics Inc (STU:65H) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

HTGMQ:USA

Address

3430 E. Global Loop, Tucson, AZ, USA, 85706

Website

https://www.htgmolecular.com

HTG Molecular Diagnostics Inc is a commercial-stage RNA platform-based life sciences company focused on advancing the promise of precision medicine. Its proprietary NGS-adapted chemistry and HTG EdgeSeq platform automates sample processing and can quickly, robustly, and simultaneously profile hundreds or thousands of molecular targets using a relatively small amount of biological samples, in liquid or solid forms. Its products include instruments, consumables, and software that combine to form its HTG EdgeSeq platform. The company's menu of HTG EdgeSeq molecular profiling panels is automated on its HTG EdgeSeq platform, applying genomic sequencing tools to quickly generate gene expression data using its simplified workflow for customers.

HTG Molecular Diagnostics (STU:65H) Headlines

No Headlines